Tango Therapeutics (TNGX) EBT Margin (2020 - 2025)
Tango Therapeutics (TNGX) posted quarterly EBT Margin of 29.5% for Q3 2025, up 28032.0% year-over-year from N/an in Q3 2024, and up 102.42% quarter-over-quarter from 1220.31% in Q2 2025.
Powered by 
Analysis
Tango Therapeutics (TNGX) EBT Margin (2020 - 2025) Analysis & Trends
Tango Therapeutics' EBT Margin history runs 6 years deep, the most recent figure standing at 29.5% for Q3 2025.
- In Q3 2025, EBT Margin rose 28032.0% year-over-year to 29.5%; the TTM figure through Mar 2026 stood at 188.2% (up 13397.0% YoY), while the FY2025 annual figure was 162.85%, up 14639.0% from the prior year.
- EBT Margin for Q3 2025 stood at 29.5%, up from 1220.31% in the prior quarter.
- The five-year high for EBT Margin was 29.5% in Q3 2025, with the low at 1220.31% in Q2 2025.
- The 5-year median for EBT Margin is 419.8% (2022), against an average of 412.22%.
- The sharpest annual moves came in 2023 and 2025: EBT Margin jumped 28926 bps in 2023, then plunged 109208 bps in 2025.
- Tango Therapeutics' EBT Margin stood at 382.59% in 2021, then declined by 18 bps to 452.49% in 2022, then dropped by 25 bps to 565.57% in 2023, then slumped by 62 bps to 913.8% in 2024, then surged by 103 bps to 29.5% in 2025.
- Business Quant data shows TNGX's EBT Margin at 29.5% in Q3 2025, 1220.31% in Q2 2025, and 738.91% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -2.67% |
| 10 | Tango Therapeutics | 3.39 Bn | 2.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 29.50% |
| Jun 30, 2025 | -1,220.31% |
| Mar 31, 2025 | -738.91% |
| Dec 31, 2024 | -913.80% |
| Sep 30, 2024 | -250.82% |
| Jun 30, 2024 | -128.23% |
| Mar 31, 2024 | -585.29% |
| Dec 31, 2023 | -565.57% |
| Sep 30, 2023 | -207.23% |
| Jun 30, 2023 | -141.43% |
| Mar 31, 2023 | -485.74% |
| Dec 31, 2022 | -452.49% |
| Sep 30, 2022 | -419.80% |
| Jun 30, 2022 | -430.69% |
| Mar 31, 2022 | -437.79% |
| Dec 31, 2021 | -382.59% |
| Sep 30, 2021 | -287.73% |
| Jun 30, 2021 | -24.87% |
| Mar 31, 2021 | -188.41% |
| Dec 31, 2020 | -1.88% |